Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised Adults

Kathleen M. Mullane, Drew J. Winston, Michael S. Wertheim, Robert F. Betts, Donald M. Poretz, Luis H. Camacho, Steven A. Pergam, Michael R. Mullane, Jon E. Stek, Tina M. Sterling, Yanli Zhao, Susan B. Manoff, and Paula W. Annunziato University of Chicago Medical Center, Illinois; University of California Los Angeles Medical Center; Hematology Oncology Associates of the Treasure Coast, Stuart, Florida; University of Rochester Medical Center, New York; Clinical Alliance for Research & Education Infectious Diseases, Annandale, Virginia; Oncology Consultants, Houston, Texas; Fred Hutchinson Cancer Research Center, Seattle, Washington; Stroger Memorial Hospitals, Chicago, Illinois; and Merck & Co., Inc., Whitehouse Station, New Jersey